Incorporating Real-World Variability in Clinical IBD Research.

作者信息

Te Velde Anje A

机构信息

Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC location AMC, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), University of Amsterdam, Amsterdam, The Netherlands.

出版信息

J Eval Clin Pract. 2025 Jun;31(4):e70117. doi: 10.1111/jep.70117.

DOI:10.1111/jep.70117

PMID:40329440

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12056217/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c9/12056217/2c9f29d8df49/JEP-31-0-g001.jpg

相似文献

[1]

Incorporating Real-World Variability in Clinical IBD Research.

J Eval Clin Pract. 2025-6

[2]

Methodology and Initial Results From a Real-World Observational Cohort of Patients With Inflammatory Bowel Disease: TARGET-IBD.

Crohns Colitis 360. 2021-5-13

[3]

Effectiveness and safety outcomes after long-term (54 weeks) vedolizumab therapy for Crohn's disease: a prospective, real-world observational study including patient-reported outcomes (POLONEZ II).

Therap Adv Gastroenterol. 2024-11-20

[4]

Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine.

BMJ Open. 2024-4-17

[5]

Challenges in IBD Research: Pragmatic Clinical Research.

Inflamm Bowel Dis. 2019-5-16

[6]

A real-world longitudinal study implementing digital screening and treatment for distress in inflammatory bowel disease (IBD): The COMPASS-IBD study protocol.

Contemp Clin Trials. 2024-10

[7]

Real-world data on the infliximab biosimilar CT-P13 (Remsima) in inflammatory bowel disease.

World J Clin Cases. 2021-12-26

[8]

Use of real-world data to assess the effectiveness of ustekinumab in treating IBD patients: a retrospective linked database study in northwest London.

Expert Opin Biol Ther. 2023

[9]

Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study.

Inflamm Bowel Dis. 2022-12-1

[10]

Influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease.

Ann Med. 2023-12

本文引用的文献

[1]

Relative Validity of the Groningen IBD Nutritional Questionnaire (GINQ-FFQ): A Food Frequency Questionnaire Designed to Assess Nutritional Intake in Patients with Inflammatory Bowel Disease.

Nutrients. 2025-1-10

[2]

Using Participatory Narrative Inquiry to Assess Experiences and Self-Experimentation with Diet Interventions in Inflammatory Bowel Disease Patients.

Nutrients. 2024-11-24

[3]

Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.

Lancet. 2024-12-14

[4]

Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial.

Lancet Gastroenterol Hepatol. 2025-1

[5]

The efficacy of CT-P13, a biosimilar of infliximab, in inflammatory bowel diseases: a systematic review and meta-analysis.

BMC Gastroenterol. 2024-11-12

[6]

An Attack on All Fronts-Extinguishing the Fire of IBD with an Integrative Approach.

Dig Dis Sci. 2025-2

[7]

Assessment of outcomes in Crohn's disease: A systematic review of randomized clinical trials to inform a multiple outcome framework.

United European Gastroenterol J. 2024-11

[8]

Noninvasive, microbiome-based diagnosis of inflammatory bowel disease.

Nat Med. 2024-12

[9]

Every problem is embedded in a greater whole.

J Eval Clin Pract. 2025-2

[10]

A Comprehensive Review of the Triangular Relationship among Diet-Gut Microbiota-Inflammation.

Int J Mol Sci. 2024-8-29

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Incorporating Real-World Variability in Clinical IBD Research.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

本文引用的文献